Recommendations for safe and effective practice of interventional cardiology during COVID-19 pandemic: Expert opinion from Jordan and Palestine
Authors:
Article info
2020-03-31
2020-04-05
65 - 73
Keywords
- PCI.
- COVID-19; Coronary artery disease
- STEMI
- acute coronary syndrome
Abstract
Corona Virus Disease 2019 (COVID-19) is a worldwide pandemic with a high mortality rate (2% to 5%) and a high infectivity compared with previous known viral respiratory illness. Data has shown that medical personnel were infected more than other people. Therefore, health care providers had to establish new protocols that balance between health care providers’ protection and patients’ benefit, and guarantee the availability of medical resources in cases of emergency. This article presents several recommendations and protocols for invasive management of coronary artery disease in our region during the COVID-19 pandemic especially after the recent increase in the number of cases in our region. We expect that these recommendations will help protect medical personnel in cardiology field from the high risk of infection of COVID-19, and eventually this would keep the cardiology team available in case of emergency. In addition, they will provide safe and effective management of patients with coronary artery disease during this pandemic.
Daralammouri, Y., Azamtta, M., Hamayel, H., Abu Jaber, D., Adas, A., Hussein, I.-E., Abu Hantash, H., Hammoudeh, A., Mousa, E., & Nasr, M. (2020). Recommendations for safe and effective practice of interventional cardiology during COVID-19 pandemic: Expert opinion from Jordan and Palestine. Palestinian Medical and Pharmaceutical Journal, 5(1), 65–73. https://doi.org/10.59049/2790-0231.1053
[1]Y. Daralammouri et al., “Recommendations for safe and effective practice of interventional cardiology during COVID-19 pandemic: Expert opinion from Jordan and Palestine,” Palestinian Medical and Pharmaceutical Journal, vol. 5, no. 1, pp. 65–73, Jun. 2020, doi: 10.59049/2790-0231.1053.
Daralammouri, Yunis, et al. “Recommendations for Safe and Effective Practice of Interventional Cardiology during COVID-19 Pandemic: Expert Opinion from Jordan and Palestine.” Palestinian Medical and Pharmaceutical Journal, vol. 5, no. 1, June 2020, pp. 65–73. Crossref, https://doi.org/10.59049/2790-0231.1053.
1.Daralammouri Y, Azamtta M, Hamayel H, Abu Jaber D, Adas A, Hussein IE, et al. Recommendations for safe and effective practice of interventional cardiology during COVID-19 pandemic: Expert opinion from Jordan and Palestine. Palestinian Medical and Pharmaceutical Journal [Internet]. 2020 Jun;5(1):65–73. Available from: http://dx.doi.org/10.59049/2790-0231.1053
Daralammouri, Yunis, Murad Azamtta, Hamza Hamayel, Dina Abu Jaber, Amro Adas, Izz-Eddein Hussein, Hadi Abu Hantash, Ayman Hammoudeh, Eyas Mousa, and Mohammed Nasr. “Recommendations for Safe and Effective Practice of Interventional Cardiology during COVID-19 Pandemic: Expert Opinion from Jordan and Palestine.” Palestinian Medical and Pharmaceutical Journal 5, no. 1 (June 2020): 65–73. https://doi.org/10.59049/2790-0231.1053.
Recommendations for safe and effective practice of interventional cardiology during COVID-19 pandemic: Expert opinion from Jordan and Palestine
المؤلفون:
معلومات المقال
2020-03-31
2020-04-05
65 - 73
الكلمات الإفتتاحية
- PCI.
- COVID-19; Coronary artery disease
- STEMI
- acute coronary syndrome
الملخص
Corona Virus Disease 2019 (COVID-19) is a worldwide pandemic with a high mortality rate (2% to 5%) and a high infectivity compared with previous known viral respiratory illness. Data has shown that medical personnel were infected more than other people. Therefore, health care providers had to establish new protocols that balance between health care providers’ protection and patients’ benefit, and guarantee the availability of medical resources in cases of emergency. This article presents several recommendations and protocols for invasive management of coronary artery disease in our region during the COVID-19 pandemic especially after the recent increase in the number of cases in our region. We expect that these recommendations will help protect medical personnel in cardiology field from the high risk of infection of COVID-19, and eventually this would keep the cardiology team available in case of emergency. In addition, they will provide safe and effective management of patients with coronary artery disease during this pandemic.
Daralammouri, Y., Azamtta, M., Hamayel, H., Abu Jaber, D., Adas, A., Hussein, I.-E., Abu Hantash, H., Hammoudeh, A., Mousa, E., & Nasr, M. (2020). Recommendations for safe and effective practice of interventional cardiology during COVID-19 pandemic: Expert opinion from Jordan and Palestine. Palestinian Medical and Pharmaceutical Journal, 5(1), 65–73. https://doi.org/10.59049/2790-0231.1053
[1]Y. Daralammouri et al., “Recommendations for safe and effective practice of interventional cardiology during COVID-19 pandemic: Expert opinion from Jordan and Palestine,” Palestinian Medical and Pharmaceutical Journal, vol. 5, no. 1, pp. 65–73, Jun. 2020, doi: 10.59049/2790-0231.1053.
Daralammouri, Yunis, et al. “Recommendations for Safe and Effective Practice of Interventional Cardiology during COVID-19 Pandemic: Expert Opinion from Jordan and Palestine.” Palestinian Medical and Pharmaceutical Journal, vol. 5, no. 1, June 2020, pp. 65–73. Crossref, https://doi.org/10.59049/2790-0231.1053.
1.Daralammouri Y, Azamtta M, Hamayel H, Abu Jaber D, Adas A, Hussein IE, et al. Recommendations for safe and effective practice of interventional cardiology during COVID-19 pandemic: Expert opinion from Jordan and Palestine. Palestinian Medical and Pharmaceutical Journal [Internet]. 2020 Jun;5(1):65–73. Available from: http://dx.doi.org/10.59049/2790-0231.1053
Daralammouri, Yunis, Murad Azamtta, Hamza Hamayel, Dina Abu Jaber, Amro Adas, Izz-Eddein Hussein, Hadi Abu Hantash, Ayman Hammoudeh, Eyas Mousa, and Mohammed Nasr. “Recommendations for Safe and Effective Practice of Interventional Cardiology during COVID-19 Pandemic: Expert Opinion from Jordan and Palestine.” Palestinian Medical and Pharmaceutical Journal 5, no. 1 (June 2020): 65–73. https://doi.org/10.59049/2790-0231.1053.
Since 2022
Cite Score (Scopus): 0.8
Time to First Decision: 3 Days
Submission to Acceptance: 45 Days
Acceptance to Publication: 64 Days
Acceptance Rate: 17%
Why should you
Publish With Us?
An-Najah National University
Nablus, Palestine
Nablus, Palestine
- P.O. Box
- 7, 707
- Fax
- (970)(9)2345982
- Tel.
- (970)(9)2345560
- (970)(9)2345113/5/6/7-Ext. 2628
- [email protected]
- EIC
- Prof. Waleed Sweileh
The Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) © 2024 by An-Najah University, Nablus, Palestine is licensed under CC BY-NC 4.0
News and Views